Gene · 54880
Papers3,332
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
721 to 740 of 3,332
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Epigenetic regulation of dental-derived stem cells and their application in pulp and periodontal regeneration. | PeerJ | 2023 | 36620748 | PubTator, text mining | PubMed |
| Peripheral B cells from patients with hepatitis C virus-associated lymphoma exhibit clonal expansion and an anergic-like transcriptional profile. | iScience | 2023 | 36619973 | PubTator, text mining | PubMed |
| Review of the Recent Changes in the WHO Classification for Pediatric Brain and Spinal Cord Tumors. | Pediatr Neurosurg | 2023 | 36617415 | PubTator, text mining | PubMed |
| Genetic, DNA methylation, and immune profile discrepancies between early-stage single primary lung cancer and synchronous multiple primary lung cancer. | Clin Epigenetics | 2023 | 36611170 | PubTator, text mining | PubMed |
| Early response evaluation by single cell signaling profiling in acute myeloid leukemia. | Nat Commun | 2023 | 36611026 | PubTator, text mining | PubMed |
| Early ependymal tumor with MN1-BEND2 fusion: a mostly cerebral tumor of female children with a good prognosis that is distinct from classical astroblastoma. | J Neurooncol | 2023 | 36604386 | PubTator, text mining | PubMed |
| Clinical utility of Todai OncoPanel in the setting of approved comprehensive cancer genomic profiling tests in Japan. | Cancer Sci | 2023 | 36601953 | PubTator, text mining | PubMed |
| Poor prognostic implications of myelodysplasia-related mutations in both older and younger patients with de novo AML. | Blood Cancer J | 2023 | 36599822 | PubTator, text mining | PubMed |
| ZBTB7A suppresses glioblastoma tumorigenesis through the transcriptional repression of EPB41L5. | Exp Mol Med | 2023 | 36596853 | PubTator, text mining | PubMed |
| Spectrum of Histopathological, Immunohistochemical, Molecular and Radiological Features in 12 Cases of BCOR::CCNB3-positive Sarcomas With Literature Review. | Int J Surg Pathol | 2023 | 36591870 | PubTator, text mining | PubMed |
| The clinical utility of integrative genomics in childhood cancer extends beyond targetable mutations. | Nat Cancer | 2023 | 36585449 | PubTator, text mining | PubMed |
| Characterization of the TBR1 interactome: variants associated with neurodevelopmental disorders disrupt novel protein interactions. | Hum Mol Genet | 2023 | 36579832 | PubTator, text mining | PubMed |
| Molecular response patterns in relapsed/refractory AML patients treated with selinexor and chemotherapy. | Ann Hematol | 2023 | 36576532 | PubTator, text mining | PubMed |
| How I Manage Transplant Ineligible Patients with Myelodysplastic Neoplasms. | Clin Hematol Int | 2023 | 36574201 | PubTator, text mining | PubMed |
| The Novel Prognostic Index Model of Combining Circulating Tumor DNA and PINK-E Predicts the Clinical Outcomes for Newly Diagnosed Extranodal NK/T-cell Lymphoma. | Hemasphere | 2023 | 36570690 | PubTator, text mining | PubMed |
| Clinical relevance of BCOR internal tandem duplication and TP53 aberration in clear cell sarcoma of the kidney. | Hum Pathol | 2023 | 36563883 | PubTator, text mining | PubMed |
| Lessons learnt, and still to learn, in first in human stem cell trials. | Stem Cell Reports | 2023 | 36563687 | PubTator, text mining | PubMed |
| Lipoblastoma in one adult and 35 pediatric patients: Retrospective analysis of 36 cases. | Exp Ther Med | 2023 | 36561624 | PubTator, text mining | PubMed |
| Non-synonymous, synonymous, and non-coding nucleotide variants contribute to recurrently altered biological processes during retinoblastoma progression. | Genes Chromosomes Cancer | 2023 | 36550020 | PubTator, text mining | PubMed |
| Bone and soft tissue tumors: clinicoradiologic-pathologic molecular-genetic correlation of novel fusion spindled, targetable-ovoid, giant-cell-rich, and round cell sarcomas. | Skeletal Radiol | 2023 | 36542130 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54880/papers?page=37